nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyamemazine—HTR2A—arteriole—focal segmental glomerulosclerosis	0.718	0.776	CbGeAlD
Cyamemazine—HTR2A—endothelium—focal segmental glomerulosclerosis	0.147	0.159	CbGeAlD
Cyamemazine—HTR2A—kidney—focal segmental glomerulosclerosis	0.0593	0.0641	CbGeAlD
Cyamemazine—Acepromazine—ALB—focal segmental glomerulosclerosis	0.0179	0.237	CrCbGaD
Cyamemazine—Thioproperazine—ALB—focal segmental glomerulosclerosis	0.0175	0.232	CrCbGaD
Cyamemazine—Pipotiazine—ALB—focal segmental glomerulosclerosis	0.0173	0.228	CrCbGaD
Cyamemazine—Clomipramine—ALB—focal segmental glomerulosclerosis	0.0136	0.18	CrCbGaD
Cyamemazine—Chlorpromazine—ALB—focal segmental glomerulosclerosis	0.00936	0.124	CrCbGaD
